Article

ReSTOR IOL good in post LASIK cataract patients

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

A total of 16 eyes of 11 patients were chosen to receive the lens after discussing thoroughly the risks, benefits and alternative lens options. Presurgical biometry was performed by partial coherence interferometry and appropriate formulae applied for IOL power calculation.

Surgery was performed using topical and intracameral anaesthesia employing phacoemulsification through clear corneal temporal incisions. Five patients underwent bilateral surgery while the remaining six required surgery in just one eye.

The results showed that all five bilateral patients were fully independent of spectacles after surgery and that, in all, ten of the eleven patients were very satisfied with the visual outcomes. One patient was moderately dissatisfied despite achieving 20/25 and J2+ uncorrected visual acuities. There were no complications of surgery and no IOLs were removed or exchanged.

Masket concluded that the ReSTOR IOL offers a good option for patients needing cataract surgery after laser photoablation.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.